09.07.2015 Views

Science Cannabis

Science Cannabis

Science Cannabis

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Referencess271Clifford, D. B. Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol13:669-671, 1983.Comitas, L. <strong>Cannabis</strong> and work in Jamaica: a refutation of the amotivationalsyndrome. Ann N Y Acad Sci 282:24-32, 1976.Consroe, P. R, and Snider, R. Therapeutic potential of cannabinoids in neurologicaldisorders. In Cannabinoids as Therapeutic Agents, R. Mechoulam, ed,pp 21-49. Boca Raton: CRC Press, 1986.Consroe, P., R. Musty, J. Rein, W. Tillery, and R. Pertwee. The perceived effectsof smoked cannabis on patients with multiple sclerosis. Eur Neurol 38:44-48,1996.De Fonseca, F. R., M.R.A. Carrera, M. Navarro, G. F. Koob, and F. Weiss. Activationof corticotropin-releasing factor in the limbic system during cannabinoidwithdrawal. <strong>Science</strong> 276:2050-2054, 1997.Devane, W. A., A. Dysarz, M. R. Johnson, L. S. Melvin, and A. Hewlett. Determinationand characterization of a cannabinoid receptor in rat brain. Mo/Pharmacol 34:605-613, 1988.Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin,D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. Isolation andstructure of a brain constituent that binds to the cannabinoid receptor. <strong>Science</strong>258:1946-1949, 1992.Di Marzo,V., D. Melck, T. Bisogno, and L. De Petrocellis. Endocannabinoids:Endogenous cannabinoid receptor ligands with neuromodulatory function.Trends Neurosci 21:521-528, 1998.Dixon, W. E. The pharmacology of cannabis indica. BMJ Nov 11:1354-1357,1899.Doll, R., R. Peto, K. Wheatley, R. Gray, and I. Sutherland. Mortality in relationto smoking: 40 years' observations on male British doctors. BMJ 309:901-910,1994.Duane Sofia, R. <strong>Cannabis</strong>: Structure-activity relationships. In Handbook of PsychopharmacologyVol. 12 L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds,pp 319-371. New York: Plenum Press, 1978.Emrich, H. M., F. M. Leweke, and U. Schneider. Towards a cannabinoid hypothesisof schizophrenia: Cognitive impairments due to dysregulation of the endogenouscannabinoid system. Pharmacol Biochem Behav 56:8030-8080,1997.Engelsman, E. L. Dutch policy on the management of drug-related problems. Br/Addiction 84:211-218, 1989.Felder, C. C., and M. Glass. Cannabinoid receptors and their endogenous agonists.Annu Rev Pharmacol Toxicol 38:179-200, 1998.Fields, H. L., and Meng, I. D. Watching the pot boil: Selective antagonists of the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!